Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Plover Bay Technologies Limited Share Issue/Capital Change 2022

Jun 28, 2022

49975_rns_2022-06-28_772bf876-1900-4e59-ba6f-62866f14493b.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [232 x 73] intentionally omitted <==

(Incorporated in Cayman Islands with limited liability)

(Stock Code: 1523)

SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO GRANT OF SHARE OPTIONS

Reference is made to the announcement of Plover Bay Technologies Limited (the “ Company ”, and its subsidiaries, the “ Group ”) dated 17 June 2022 in relation to the grant of share options (the “ Announcement ”). Unless otherwise defined or the context otherwise requires, capitalised terms used herein shall bear the same meaning as those defined in the Announcement.

The Company wishes to further inform the shareholders of the Company and potential investors that the total number of Options granted to the 8 eligible consultants was 800,000. These consultants provided software and system development and maintenance services to the Company. The Company granted Options to them due to their satisfactory performances over the past 3 years and hoped to encourage them to continue providing services to the Company in the future.

By Order of the Board of Plover Bay Technologies Limited Chan Wing Hong Alex Chairman and executive Director

Hong Kong, 28 June 2022

As at the date of this announcement, the executive Directors are Mr. Chan Wing Hong Alex, Mr. Chau Kit Wai, Mr. Chong Ming Pui and Mr. Yeung Yu; the independent non-executive Directors are Dr. Yu Kin Tim, Mr. Ho Chi Lam and Mr. Wan Sze Chung.